ArticleJournal of translational medicine2016

Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.

Hong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.